Want to join the conversation?
Evercore ISI analyst David Togut questions about FY17 target for closed sales. $BR says that there's not a lot beyond it other than to move the target up. $BR is always going to look to add to its sales capabilities and drive the numbers higher. But until it can actually get to the numbers, $BR feels a modest increase is a prudent way to go forward
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?